The University of Southampton
University of Southampton Institutional Repository

Screening for nonalcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes

Screening for nonalcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes
Screening for nonalcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes
Aim

Despite the high prevalence and serious clinical implications of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM), NAFLD is usually overlooked during routine diabetes care. This study explored the proportion of NAFLD cases and increased liver fibrosis (LF), and the association between LF and either chronic kidney disease (CKD) or cardiovascular complications in T2DMpatients.

Methods

The study included 137 patients with non-insulin-treated T2DM and no known liver disease consecutively attending our diabetes outpatients’ service who underwent liver ultrasonography and liver stiffness measurement (LSM) using vibration-controlled transient elastography (FibroScan®).

Results

The proportion of patients with hepatic steatosis on ultrasonography was 73.7%, and the proportion with significant LF was 17.5% with an LSM cut-off ≥ 7 kPa or 10.2% with an LSM cut-off ≥ 8.7 kPa. The presence of CKD (estimated GFR < 60 mL/min/1.73 m2 and/or abnormal albuminuria) increased significantly across LSM tertiles (from around 15% in tertile 1 to 45% in tertile 3). Cardiovascular complications (previous ischaemic heart disease, ischaemic stroke, permanent atrial fibrillation) also tended to increase across LSM tertiles (from around 15% to 30%). After adjusting for established risk factors and potential confounders, LSM tertile 3 remained significantly associated with an approximately threefold higher risk of prevalent CKD (adjusted OR: 3.28, 95% CI: 1.22–8.90; = 0.019), but not for cardiovascular complications.

Conclusion

These results suggest that NAFLD and significant LF (as assessed by FibroScan®) are very commonly seen in T2DM outpatients with no known liver disease attending a secondary-care diabetes service, and that increased LF is associated with a greater proportion of chronic vascular complications, especially CKD.

CKD, Liver fibrosis, NAFLD, Type 2 diabetes
1262-3636
296-303
Mantovani, Alessandro
19fc8a1f-60fe-403a-b70e-6b6884929e03
Turino, Teresa
cd495039-7f64-4251-8edb-ac84ef57a2bb
Lando, Maria Giovanna
0d0ba521-5501-4ba6-9685-fffa53e2bc56
Gjini, Kamela
4439cb20-8683-461b-8687-236991bf57c2
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Zusi, Chiara
8d0fd85d-1867-4819-87a0-571e86011616
Ravaioli, Federico
2a303b03-659a-4080-83d9-74ea4742d8c4
Colecchia, Antonio
2d82adeb-fe1c-4743-b32f-9bb82f067a9e
Maffeis, Claudio
86024c4a-1230-4509-8d5b-d0d3ea6b6182
Salvagno, Gianluca
feb9c063-bcf6-4333-9c32-0ffad926e26d
Lippi, Giuseppe
60e57929-6432-4a2d-b2e1-78d48b74e8f2
Bonora, Enzo
68c801d0-43f4-4736-ae51-209498e44c07
Targher, Giovanni
043e0811-b389-4922-974e-22e650212c5f
Mantovani, Alessandro
19fc8a1f-60fe-403a-b70e-6b6884929e03
Turino, Teresa
cd495039-7f64-4251-8edb-ac84ef57a2bb
Lando, Maria Giovanna
0d0ba521-5501-4ba6-9685-fffa53e2bc56
Gjini, Kamela
4439cb20-8683-461b-8687-236991bf57c2
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Zusi, Chiara
8d0fd85d-1867-4819-87a0-571e86011616
Ravaioli, Federico
2a303b03-659a-4080-83d9-74ea4742d8c4
Colecchia, Antonio
2d82adeb-fe1c-4743-b32f-9bb82f067a9e
Maffeis, Claudio
86024c4a-1230-4509-8d5b-d0d3ea6b6182
Salvagno, Gianluca
feb9c063-bcf6-4333-9c32-0ffad926e26d
Lippi, Giuseppe
60e57929-6432-4a2d-b2e1-78d48b74e8f2
Bonora, Enzo
68c801d0-43f4-4736-ae51-209498e44c07
Targher, Giovanni
043e0811-b389-4922-974e-22e650212c5f

Mantovani, Alessandro, Turino, Teresa, Lando, Maria Giovanna, Gjini, Kamela, Byrne, Christopher, Zusi, Chiara, Ravaioli, Federico, Colecchia, Antonio, Maffeis, Claudio, Salvagno, Gianluca, Lippi, Giuseppe, Bonora, Enzo and Targher, Giovanni (2020) Screening for nonalcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes. Diabetes & Metabolism, 46 (4), 296-303. (doi:10.1016/j.diabet.2019.11.004).

Record type: Article

Abstract

Aim

Despite the high prevalence and serious clinical implications of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM), NAFLD is usually overlooked during routine diabetes care. This study explored the proportion of NAFLD cases and increased liver fibrosis (LF), and the association between LF and either chronic kidney disease (CKD) or cardiovascular complications in T2DMpatients.

Methods

The study included 137 patients with non-insulin-treated T2DM and no known liver disease consecutively attending our diabetes outpatients’ service who underwent liver ultrasonography and liver stiffness measurement (LSM) using vibration-controlled transient elastography (FibroScan®).

Results

The proportion of patients with hepatic steatosis on ultrasonography was 73.7%, and the proportion with significant LF was 17.5% with an LSM cut-off ≥ 7 kPa or 10.2% with an LSM cut-off ≥ 8.7 kPa. The presence of CKD (estimated GFR < 60 mL/min/1.73 m2 and/or abnormal albuminuria) increased significantly across LSM tertiles (from around 15% in tertile 1 to 45% in tertile 3). Cardiovascular complications (previous ischaemic heart disease, ischaemic stroke, permanent atrial fibrillation) also tended to increase across LSM tertiles (from around 15% to 30%). After adjusting for established risk factors and potential confounders, LSM tertile 3 remained significantly associated with an approximately threefold higher risk of prevalent CKD (adjusted OR: 3.28, 95% CI: 1.22–8.90; = 0.019), but not for cardiovascular complications.

Conclusion

These results suggest that NAFLD and significant LF (as assessed by FibroScan®) are very commonly seen in T2DM outpatients with no known liver disease attending a secondary-care diabetes service, and that increased LF is associated with a greater proportion of chronic vascular complications, especially CKD.

Text
LSM and CKD in T2DM - Accepted Manuscript
Download (228kB)
Text
Figure 1 - Accepted Manuscript
Download (65kB)
Text
Figure 2 - Accepted Manuscript
Download (77kB)

More information

Accepted/In Press date: 9 November 2019
e-pub ahead of print date: 28 November 2019
Published date: 1 September 2020
Keywords: CKD, Liver fibrosis, NAFLD, Type 2 diabetes

Identifiers

Local EPrints ID: 435781
URI: http://eprints.soton.ac.uk/id/eprint/435781
ISSN: 1262-3636
PURE UUID: 5052d716-7d18-4416-8cf8-30258d103649
ORCID for Christopher Byrne: ORCID iD orcid.org/0000-0001-6322-7753

Catalogue record

Date deposited: 20 Nov 2019 17:30
Last modified: 17 Mar 2024 05:02

Export record

Altmetrics

Contributors

Author: Alessandro Mantovani
Author: Teresa Turino
Author: Maria Giovanna Lando
Author: Kamela Gjini
Author: Chiara Zusi
Author: Federico Ravaioli
Author: Antonio Colecchia
Author: Claudio Maffeis
Author: Gianluca Salvagno
Author: Giuseppe Lippi
Author: Enzo Bonora
Author: Giovanni Targher

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×